CLINICAL SUPPLY MANAGEMENT ARTICLES
Sourcing Through The Tariff Mess: What 2026 Actually Means For Clinical Supply
US tariff changes are reshaping clinical supply sourcing. Learn how pharmaceutical duties, country-of-origin documentation and temporary import provisions affect trial materials.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
Explore the need for advanced capabilities beyond basic RTSM and the importance of having experienced teams behind IRT solutions to navigate complexities and ensure successful trial execution.
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.